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Abstract: Sepsis, a dysregulated immune system response to infection, is among the leading 
causes of morbidity, mortality, and cost overruns in the Intensive Care Unit (ICU). Early prediction 
of sepsis can improve situational awareness amongst clinicians and facilitate timely, protective 
interventions. While the application of predictive analytics in ICU patients has shown early 
promising results, much of the work has been encumbered by high false-alarm rates. Efforts to 
improve specificity have been limited by several factors, most notably the difficulty of labeling 
sepsis onset time and the low prevalence of septic-events in the ICU. Here, we present DeepAISE 
(Deep Artificial Intelligence Sepsis Expert), a recurrent neural survival model for the early 
prediction of sepsis. We show that by coupling a clinical criterion for defining sepsis onset time 
with a treatment policy (e.g., initiation of antibiotics within one hour of meeting the criterion), one 
may rank the relative utility of various criteria through offline policy evaluation. Given the optimal 
criterion, DeepAISE automatically learns predictive features related to higher-order interactions 
and temporal patterns among clinical risk factors that maximize the data likelihood of observed 
time to septic events. DeepAISE has been incorporated into a clinical workflow, which provides 
real-time hourly sepsis risk scores. A comparative study of four baseline models indicates that 
DeepAISE produces the most accurate predictions (AUC=0.90 and 0.87) and the lowest false 
alarm rates (FAR=0.20 and 0.26) in two separate cohorts (internal and external, respectively), 
while simultaneously producing interpretable representations of the clinical time series and risk 
factors.  
 
Introduction  
Sepsis is a syndromic, life-threatening condition that arises when the body's response to infection 
injures its own internal organs (1). Though the condition lacks the same public notoriety as other 
conditions like heart attacks, 6% of all hospitalized patients in the United States carry a primary 
diagnosis of sepsis as compared to 2.5% for the latter(2). When all hospital deaths are ultimately 
considered, nearly 35% are attributable to sepsis (2). This condition stands in stark contrast to heart 
attacks which have a mortality rate of 2.7-9.6% and only cost the US $12.1 billion annually, 
roughly half of the cost of sepsis (3).  
Starting in 2004 the Surviving Sepsis Campaign (SSC) began addressing the variations in clinical 
treatment regimens for sepsis and septic shock through the promulgation of evidence based 
practice guidelines called “sepsis bundles”(4). These bundles consolidate the results of numerous 
investigations that have repeatedly demonstrated improvement in sepsis outcomes after the timely 
administration of broad-spectrum antibiotics, Intravenous (IV) fluids, and vasopressors when 
indicated (5–8). The most recent recommendation from the SSC is a 1-hr bundle that in addition 
to obtaining diagnostic tests like cultures and lactate levels, prescribes standard treatment with 
broad spectrum antibiotics, IV fluid, and vasoactive drugs if necessary, all within an hour of a 
sepsis diagnosis (9). While there are effective protocols for treating sepsis once it has been 
diagnosed there still exists challenges in reliably identifying septic patients early in their course.  
In recent years, the increased adoption of electronic medical records (EHRs) in hospitals (10) has 
motivated the development of machine learning based surveillance tools for detection or 
classification (11–15) and prediction (11, 16–18) of patients with sepsis or septic shock. For 
prediction of sepsis in particular, Desautels et al. (11) used a proprietary machine learning 
algorithm called InSight to achieve an Area Under the Curve (AUC) of 0.78 in predicting onset of 
sepsis four hours in advance. Nemati et al. (16) used a modified Weibull-Cox model on a 
combination of low-resolution Electronic Medical Record (EHR) data and high-resolution vital 
signs time series data to predict onset of sepsis four hours in advance with an AUC of 0.85. Other 
works (17, 18) have focused on developing models to predict septic shock, which occurs when 
sepsis leads to low blood pressure that persists despite treatment with intravenous fluids. However, 
a direct comparison of these methods is not possible for several reasons: 1) utilization of different 
labels for sepsis and septic shock, 2) variations in prediction horizon (finite horizon prediction vs 
infinite horizon prediction, 3) differences in frequency of prediction (single event classification vs 
sequential prediction), and 4) variations in study design and disease prevalence (case-control 
design vs calibrated real-world prevalence models). To date most sepsis prediction research has 
failed to make the transition into viable Clinical Decision Support (CDS) systems owing to the 
relatively low clinical tolerance for false-alarms (19), as well as the interpretability and workflow 
integration requirements for CDS systems (20, 21). False clinical alarms not only increase the 
cognitive load on clinicians but can also expose patients to unnecessary antibiotics and may 
contribute to emergence of antibiotic resistance pathogens (22). Nevertheless, identifying and 
treating true cases of sepsis before they are clinically apparent is categorically one of the most 
important needs for modern medicine to address.  
Consistently identifying the onset time for sepsis presents unique challenges because the condition 
manifests as constellation of signs and symptoms with significant variability in presentation and 
timing. The Third International Consensus Definitions for Sepsis (Sepsis-3) guidelines have 
provided two primary criteria for making a formal diagnosis of sepsis: 1) There must be a suspicion 
for infection (indicated by the administration of antibiotics for at least 72hrs with the concomitant 
collection of cultures) 2) There must be a two-point increase in the SOFA (Sequential Organ 
Failure Assessment) score (1). These criteria have associated time points and from these time 
points, sepsis can be consistently labeled. While the Sepsis-3 criterion is considered the current 
standard for labeling sepsis onset time, previous consensus criteria for sepsis (based on Sepsis-1 
and Sepsis-2 definitions) (23, 24) remain in wide use. Additionally, there are other sepsis criteria 
developed by the Center for Disease Control (CDC) and Center for Medicare and Medicaid 
Services (CMS) for use in surveillance studies (25, 26).  
When applied to the same patient population, the execution of aforementioned criteria often leads 
to significant variability in the sepsis onset times. Therefore, a question of interest is what 
consensus criteria for sepsis (on average) is likely to result in improved patient outcomes if coupled 
with appropriate treatment protocols. In this work, we show that by coupling a criterion with a 
treatment policy (e.g., initiation of antibiotics within an hour of meeting the criterion), one may 
use the framework of Attributable treatment effect estimates (ATEE) (27) to rank the relative 
utility of various criteria through policy evaluation. The ATEE framework allows one to ask 
outcome-specific counterfactual questions such as 'what-if a patient had received antibiotics 4-6 
hours prior to meeting a given sepsis onset time?' or ‘what-if a treatment bundle requirement was 
met within 3-hours of clinical recognition?’. This is equivalent to evaluating the expected reward 
(e.g. hospital survival or 60 days survival) associated with a counterfactual treatment policy (e.g., 
early detection of sepsis via an automated algorithm followed by administration of antibiotics) 
compared to the actual hospital policy (e.g., suspicion of sepsis by a clinician followed by 
administration of antibiotics).  
The three primary contributions of this work are:  
a) An ATEE framework to compare the various consensus criteria of sepsis and choose the 
most optimal amongst them. 
b) A deep learning framework for prediction of sepsis (called DeepAISE) that reduces 
incidents of false alarms by automatically learning predictive features related to higher-
order interactions and temporal patterns among clinical risk factors for sepsis. Unlike 
comparable models, this algorithm maintains interpretability by tracking the top relevant 
features contributing to the sepsis score as a function of time, providing clinicians with 
rationale for alerts. Most importantly, DeepAISE is a generalizable model developed using 
25,000 patient admissions to the Intensive Care Units (ICUs) at two Emory University 
hospitals and over 40,000 ICU admissions from the Medical Information Mart for Intensive 
Care-III (MIMIC-III) ICU database. 
c) A software platform that integrates the DeepAISE framework with live streaming patient 
data, computes sepsis risk scores in real-time, and presents them in an interpretable, 
clinically meaningful fashion. The platform is scalable and can be integrated into clinical 
workflow. 
Results  
Study design and patient cohorts 
The DeepAISE model was trained and validated on two separate patient cohorts. The Emory cohort 
consisted of all patients admitted to the ICUs at two hospitals within the Emory Healthcare system 
in Atlanta, Georgia from 2014 to 2018. External validation of the DeepAISE model was performed 
on the MIMIC-III database (28), which is a publicly available database containing de-identified 
clinical data of patients admitted to a medical center in Boston, Massachusetts from 2001 to 2012. 
The complete set of patient features (Appendix C of Supplementary Material) was grouped into 
three categories: clinical features (e.g. heart rate, mean arterial pressure, etc.), laboratory test 
results (e.g. hemoglobin, creatinine, etc.) and demographic/history/context features (e.g.  age, care 
unit type, etc.). 
In both the cohorts, the Third International Consensus Definition of Sepsis (Sepsis-3) (1, 29) 
criterion was used to assign sepsis onset time (tsepsis-3) when two conditions were simultaneously 
satisfied: 1) there was a clinical suspicion of infection (tsuspicion) and 2) there was a two point 
increase in SOFA score (tSOFA). Similarly, all patients were labeled for the Center for Disease 
Control (CDC) onset time of sepsis (tsepsis-CDC) according to a modified version of the criterion 
developed the CDC (25) when two conditions were simultaneously satisfied: 1) there was a clinical 
suspicion of infection and 2) there was an eSOFA score of one or higher (teSOFA) (30).  The labels 
of tsuspicion, tSOFA, tsepsis-3, teSOFA, and tsepsis-CDC are used extensively throughout this study to define 
key time points and are clearly described in Table 1. 
The Emory cohort consisted of a total of 25,820 patients (see Table S1 for patient characteristics), 
1,445 of whom met the Sepsis-3 criterion four hours or later after ICU admission (29). Those who 
developed sepsis tended to have a slightly higher percentage of male patients compared to non-
septic patients (55.2% vs. 53.2%) and had more comorbidities (Charlson Comorbidity Index [CCI] 
3 vs. 2). Septic patients had longer median lengths of ICU stay (5.9 vs. 1.9 days), higher median 
SOFA scores (5.0 vs. 1.7), and higher hospital mortality (15.2% vs. 3.5%).   The median 
[interquartile range (IQR)] time from ICU admission to tsepsis-3 in the Emory cohort was 24 [9, 63] 
hours. In comparison, the median [IQR] time from ICU admission to tsepsis-CDC in the Emory cohort 
was 31 [11, 70] hours. Similar patterns were observed for the MIMIC-III external validation cohort 
(Appendix E of Supplementary Material, Table S3). 
Attributable treatment effect estimates 
We used the framework of attributable treatment effect-size estimates (ATEE) to quantitatively 
compare the two aforementioned consensus criteria (namely tsepsis-3 and tsepsis-CDC) for labeling 
sepsis onset time (see Material and Methods for more details).  We considered four different 
treatment levels corresponding to different antibiotic administration delay intervals with respect 
to the onset time of sepsis, namely [-24, –6), [-6, 0), [0, 3), and [3, 24] hours. The ATEE 
framework was used to assess the survival effects of early or late antibiotics administration with 
respect to each criterion (see Table 2). Entries in the table correspond to expected improvement 
in outcome (defined as not dying or not getting transferred to a hospice) as estimated by Eq. 1. In 
all cases, early administration of antibiotics resulted in a net improvement in outcome, compared 
to the existing clinical policy. The results from Table 2 suggest that if a clinical policy based on 
prediction of tsepsis-3 six hours in advance followed by administration of antibiotics was put in 
place, one could have expected 8.2 [7.4, 9.9] % improvement in patient outcomes. Whereas a 
clinical policy based on prediction of tsepsis-CDC six hours in advance followed by administration 
of antibiotics could have resulted in 0.8 [-0.2, 5.3] % improvement in patient outcomes.  
DeepAISE prediction performance for sepsis onset 
The DeepAISE model was trained to predict the early onset of sepsis (tsepsis-3). DeepAISE made 
hourly predictions, starting four hours after ICU admission, and considered a total of 65 features 
that were commonly available in the EHR. The Emory training and testing sets contained a total 
of approximately 500,000 and 125,000 hourly prediction windows, respectively. A complete list 
of all the input features is provided in Appendix C of Supplementary Material.  
The DeepAISE model reliably predicted tsepsis-3 four hours in advance with an AUC of 0.90 
(specificity of 0.80 at sensitivity of 0.85) on the Emory testing set. Slightly lower performance was 
observed for the MIMIC testing set, with the DeepAISE model achieving an AUC of 0.87 for 
predicting tsepsis-3 four hours in advance (see Table 3 for more details). To assess the impact of 
changes in institutional practices and patient populations over time we performed an experiment 
in which a model trained on Emory year-based training set (patients in Emory cohort from the year 
2014 through 2017) was applied to a holdout test set collected from 2017 to 2018 (Emory year-
based holdout set). The DeepAISE model achieved an AUC of 0.88 on the Emory year-based 
holdout set (see Fig. S4 for more details) suggesting that the model was not adversely impacted by 
changes in patient population or clinical practices over time.  
DeepAISE performance against other baselines 
The DeepAISE model is a composite model made of a class of Recurrent Neural Network (RNN) 
models known as Gated Recurrent Units (GRUs) (31) that feeds into a Weibull Cox Proportional 
Hazards (WCPH) model (see section ‘Development of the DeepAISE model’ in methods for more 
information). This architecture was chosen in the context of predicting sepsis onset time as a time-
to-event analysis and considering that temporal changes in patients’ physiology are important for 
the early prediction of sepsis. We assessed the utility of this model architecture by comparing 
performance of DeepAISE against three different baseline models: 1) a Logistic Regression (LR) 
model, 2) a Weibull-Cox proportional hazards (WCPH) model, and 3) a Feedforward Neural 
Network (FFNN) with two layers of 100 hidden units and a final WCPH layer for prediction of 
onset of sepsis (See Fig.1). A more comprehensive comparison of DeepAISE with other baseline 
models can be found in Supplementary Material (See Fig. S3). 
Across all prediction windows, DeepAISE consistently outperformed all other classifiers 
(p<0.001; when AUC of DeepAISE was compared with AUC of other baseline methods) for 
prediction of tsepsis-3 (See Fig. 1, Fig. S3 and Table S2) and across all prediction windows, 
indicating that capturing temporal trends and interactions among the risk factors is important for 
accurate prediction of sepsis. The performance of all the models decreased with the increase in 
prediction horizon. For DeepAISE, the AUC on the Emory testing set decreased from 0.90 at 4-
hour prediction horizon to 0.88 at 12-hour prediction horizon. We also observed that these findings 
were consistent with the MIMIC testing set (Fig. S8).  
In addition, a FFNN trained to predict tsepsis-3 with delta change in SOFA score as input achieved 
0.54 AUC on Emory testing set, and a FFNN trained to predict tsepsis-3 with delta change in SOFA 
score and static covariates (such as age, gender, weight etc.) as inputs achieved 0.68 AUC on the 
Emory testing set. The above results show that DeepAISE scores were not simply recapitulations 
of the SOFA scores. 
 
 
Clinical interpretation of DeepAISE predictions 
While performance characteristics of machine learning algorithms are important, providing 
interpretable data to the bedside clinicians that can guide diagnosis and therapeutic interventions 
is a critical requirement of CDS systems. To date many sepsis models have failed to demonstrate 
which physiologic aberrations contributed to the model’s prediction, compelling many to refer to 
them as “black boxes” DeepAISE allayed these concerns by continually revealing the top patient 
features contributing to its predicted risk scores. Unlike many other algorithms, DeepAISE is 
uniquely interpretable as evidenced in Fig. 2 in which the trajectory of a septic patient who 
developed pneumonia in the ICU is displayed. In this visualization, the sepsis risk score predicted 
by the model is shown along with vital sign trends, and most notably, the most relevant features 
contributing to the risk score. In this example, early deterioration of the patient’s respiratory status 
was detected by the model. The model identified aberrations in PaO2, PaCO2, blood pH and 
Glasgow coma score (GCS) as some of the top features relevant to its prediction. The importance 
of each feature was calculated using the magnitude and sign of the associated relevance scores, in 
a fashion similar to saliency maps for convolutional neural networks (32). To validate the clinical 
interpretability of the DeepAISE model, analysis of the most relevant features starting 10 hours 
prior to and ending at tsepsis-3 was conducted (see Fig. 4). This investigation revealed that DeepAISE 
ascribed importance to several features that have already been identified as risk factors for sepsis 
such as recent surgery, length of ICU stay, heart rate, GCS, white blood cell count, and 
temperature, and some less appreciated but known factors such as Phosphorus (or 
hypophosphatemia) (33). This analysis provides a global view of model interpretability, whereas 
the individual relevance scores provide a local view of interpretability by listing the top features 
contributing to the risk scores at each hourly point in time. Perturbation analysis revealed that the 
globally important features may not provide an accurate view of the top contributing factors to the 
individual risk scores. We observed that treating the top locally important features as missing 
values yielded a significantly lower AUC compared with a similar analysis replacing the globally 
most important features. (See Fig. 4; Additionally, refer to Appendix F of Supplementary Material 
for a more thorough analysis of global model interpretability vs local model interpretability).  
 
Inferring significance of individual patient trajectories 
Clinicians have long appreciated that trends in patient metrics are often more telling than discrete 
point values. The high dimensional nature of the data used to represent a patient is challenging to 
represent. Display of patient trajectories as they pass from states of sickness to health provides yet 
another opportunity to inform the clinician about a patient's expected clinical course.  
Each point on the manifold shown in Fig. 3 is a 3D representation (projection) of the patient’s 65 
features, constructed via first learning a 100-dimensional representation (last layer of the 
DeepAISE model) followed by dimensionality reduction via Spectral clustering (34).  Two 
exemplar patient trajectories are presented in Fig. 3. Patient 2 was in a state of good health 
(specifically no suspicion for infection) prior to developing a subdural hemorrhage which 
prompted admission. This patient went on to be diagnosed with a ventilator associated pneumonia 
two days after an emergent craniectomy. In contrast Patient 1, who was several weeks status post 
craniectomy for stroke, was readmitted with a culture positive pneumonia present on admission. 
The manifold in Fig. 3 shows that trajectories for patient 1 and 2 follow similar terminal patterns; 
however, correctly assigns them different starting positions with patient 2 starting from a 
comparatively higher risk cluster. The specific trajectory of an ICU patient may be useful in 
categorizing infectious phenotypes and detecting anomalous physiological dynamics. 
 
DeepAISE user interface and tele-ICU workflow integration   
The goal of any CDS system is to improve patient outcomes and reduce hospitalization costs; 
however, actualization of these goals is incumbent upon clinical teams embracing and actually 
employing the technology. The integration of a CDS system into clinical workflows depends on 
many factors, and therefore the development of the DeepAISE UI (User Interface) involved 
nursing stakeholders in our tele-ICU center.  
Appreciating the workflow of the tele-ICU staff was a critical component of ensuring that the 
developed UI was both useable and interpretable. Nursing stakeholders identified the key tasks in 
the tele-ICU as consisting of the following: routine patient assessment, sepsis risk assessment, 
communication with the bedside clinical team, and physician initiation of therapeutic 
interventions. A minimal user interface (UI) that enhanced workflow awareness, provided easy 
actionability, and ensured data integrity was built after soliciting requirements from the 
aforementioned stakeholders in early 2017.  
The resultant UI shown in Fig. 6 was designed to present a list of patients sorted by sepsis risk 
score. Square cards that include the sepsis risk score as well as the change in score over the past 
hour are used to represent a single patient. Individual cards can be flipped via a single mouse-click 
to reveal the top factors contributing to the presented score. To improve individual and unit 
situational awareness regarding patient interventions and assessments, users can drag-and-drop 
patient cards into columns representing different treatment categories. 
Data integrity assessment was carried out via manual chart-review of patient records (vitals, labs, 
etc.) to ensure that the displayed patient data on the user interface matched the corresponding 
values within the clinician facing EHR application (Cerner’s PowerChart). Overall, 100% of users 
(five out of five tele-ICU nurses) reported improvement in usability with the addition of top 
contributing factors to the risk score and workflow related features into the user interface.  
 
Discussion  
The major contribution of this effort is a framework for joint optimization of features (via deep 
learning) and labels (through counterfactual reasoning) for training predictive models in clinical 
settings. We showed that the ATEE framework can be used to optimally select among multiple 
criteria of sepsis (i.e., Sepsis-3 criterion and Sepsis-CDC criterion) while simultaneously providing 
an estimate of the effect size associated with early or late antibiotics administration. Moreover, a 
deep learning model was used to automatically learn complex features, including temporal trends 
and higher-order interactions among the risk factors, to accurately predict the likelihood of sepsis 
in patients admitted to the ICU up to 12 hours in advance. Finally, satisfaction amongst users of 
our CDS system was most greatly impacted by the enhancement of clinical interpretability of the 
findings through a workflow-aware UI that incorporated a patient’s trajectory and the key factors 
contributing to their risk score. 
DeepAISE was developed to predict two time-points of interest in this study, namely tsepsis-3 
(Sepsis-3 criterion), and tsepsis-CDC (Sepsis-CDC criterion). Counterfactual reasoning indicated that 
there would be an approximate 8% improvement in patient survival if a clinical policy of 
administrating antibiotics 6-hours prior to tsepsis-3 was implemented. Note, this improvement was 
with respect to the actual antibiotic administration times (i.e. the clinical policy) at a tertiary 
academic medical center. Similar analysis revealed a marginal expected improvement in survival 
when considering a clinical policy based on administration of antibiotics 6-hours prior to tsepsis-CDC. 
Notably, the onset time of sepsis according to the CDC criterion often occurred approximately 6-
7 hours after the sepsis-3 onset time. This delay was likely attributable to the more stringent 
eSOFA scoring method that requires an adverse change of  ≥ 50% from a patients’ baseline value 
in order to mark an increase in individual organ scores. When considering interval of [-24, -6) 
hours prior to onset time of sepsis we did not observe any statistically significant difference 
between the expected outcomes (roughly 8% for both criteria). However, prediction of onset time 
of sepsis degrades with longer prediction windows and one may expect higher false alarms and 
lower predictive value over the [-24, -6) hours interval. We observed that the six hours ahead 
prediction AUC of DeepAISE (on Emory testing set) was 0.89 for tsepsis-3. Additionally, the 
performance of DeepAISE expectedly dropped as the prediction window increased from 2 to 12 
hours. All the findings in patients were externally validated with the MIMIC-III cohort.  
Another advantage of the proposed deep learning approach is in its ability to provide the top factors 
contributing to the risk score for every point in time for each patient (i.e., local interpretability). 
The distinction between the global and local notions of interpretability (i.e., what features are 
contributing to the sepsis risk score for the cohort at large versus an individual patient’s hourly 
prediction window) is most notable when dealing with models capable of capturing higher order 
interactions and temporal trends in the data. As a result, the degree of risk associated with a factor 
(e.g., temperature) is a function of other factors in a multiplicative sense (e.g., hypothermia and 
old age are together a greater risk factor than either by itself). Similarly, the temporal context of a 
risk factor can alter its contribution to a given risk score calculation (e.g., leukocytosis immediately 
after surgery may not be unexpected and may contribute differently to the risk for sepsis). These 
multiplicative and temporal factors (which are captured by the DeepAISE model) result in 
variations in the importance of risk factors when viewed from a local, hourly prediction perspective 
for each patient. Note that traditional logistic regression models and decision trees are not capable 
of making such inferences unless the relevant features are hand-crafted by the experts and included 
in the model.  
The DeepAISE algorithm was implemented in a real-time setting and a decision support user 
interface (UI) was designed to communicate the risk scores to the clinical team. A major barrier to 
wide adoption of modern machine learning based CDS tools in clinical practice has been their 
“black box” nature (30). While it is important to design deep learning models with high 
performance, it is imperative to build models that provide interpretable data to bedside clinicians 
that can augment their understanding of the disease process and can contribute to the selection and 
initiation of appropriate treatments. DeepAISE was designed to be transparent by: 1) continually 
revealing the top causes contributing to the sepsis risk score (see Fig. 2), 2) providing a lower 
dimensional view of the patients’ trajectory (see Fig. 3), and 3) providing a prioritized list of 
patients at risk for sepsis (see Fig. 6). These three attributes allow the bedside clinician to identify 
pathologic deviations from expected physiology early and in real-time throughout the duration of 
patients’ hospital admission. Moreover, we have shown that the top causes can be broken down 
into two categories of positively and negatively contributing factors to the risk score (see Appendix 
F of supplementary material). Notably, this analysis shed insight on the input features contributing 
significantly to the sensitivity (positive contributors) and specificity (negative contributors) of 
DeepAISE (see Fig. 4). Since one of the key limitations of using EHR data is the intermittent 
nature of laboratory measurements, we hypothesize that one may use the knowledge of the top 
contributing factors to protocolize the ordering of laboratory tests, to ensure specific updated 
measurements of these factors are available to the algorithm, thus improving model sensitivity and 
specificity. 
In recent years, several machine learning-based models for early prediction of sepsis and septic 
shock have been proposed; although variations in experimental design and definitions of sepsis 
make a direct comparison of these methods impractical. Desautels et al. (11) proposed a proprietary 
machine learning model called InSight to predict sepsis in ICU patients. Their model used a 
combination of vital signs, pulse oximetry, GCS, and age as input features. An earlier version of 
this algorithm relied on the Sepsis-3 definition (specifically tSOFA) to train its model and was able 
to reliably identify (detect) patients at the time they had met the Sepsis-3 criteria, with a 4-hours 
ahead prediction AUC of 0.74, which is comparable to performance reported by Amland et al. 
(35). Following the Sepsis-3 definition, Nemati et al. (16) achieved an AUC of 0.85 for 4 hours 
ahead prediction of sepsis, by combining 65 data points including low-resolution data from the 
EHR and high-resolution vital sign time series features from the bedside monitors. The superior 
performance of DeepAISE in comparison to the abovementioned models can be attributed to 
employment of an RNN-based model that captures patients’ clinical trajectory.  
Experimental design can have a pronounced effect on the reported AUC of machine learning 
algorithms. A commonly utilized method known as the ‘case-control’ design (which includes the 
majority of studies involving biomarkers) significantly overestimates the true prevalence of 
positive labels and can result in highly optimistic reported performances in the literature (29) when 
compared to a ‘sequential prediction’ design (16). Assuming a sepsis prevalence of 8% in the ICU 
population (after excluding all cases of sepsis developed before ICU admission), a median time-
to-sepsis of 23 hours, and a 6-hours ahead prediction window, typically only 1-2% of the observed 
windows include a positive label for sepsis. The case-control study design assumes the timing of 
sepsis is known a priori and seeks to show that certain physiological or biomarker signatures 
preceding this time are significantly different than that of the non-septic control patients. The 
resulting algorithms, which are tuned to a 50% prevalence of positive labels, tend to produce high 
rates of false alarms when deployed prospectively. 
 
In general, statistical evaluation methods (such as the AUC) have a limited applicability when 
evaluating the clinical utility of such algorithms, although they can provide quantitative metrics 
for the comparison of various algorithms. In practice, performance metrics are only meaningful 
when coupled with appropriate clinical protocols that describe the course of action in response to 
the associated risk alerts. Simple clinical actions (such as ‘snoozing’ the alarm for X hours if the 
patient did not meet the clinical threshold to initiate therapy) can significantly alter the false-
alarm rate (defined as 1-Specificity) and the associated AUC of an algorithm in practice. 
While we have strictly adhered to the Sepsis-3 criteria for defining septic labels in our study, it has 
been noted that this criterion is too stringent and the sensitivity of early detection is lost to an 
increased specificity (36, 37). The Sepsis-3 criterion utilized in this study is an acausal clinical 
construct for demarcating the onset time of sepsis, and as such cannot be used in a clinical setting 
for early detection of sepsis; however, a predictive analytic risk score when trained to predict the 
associated onset-time can combine the specificity advantages of Sepsis-3 with the benefits of early 
recognition. Moreover, it is critical to appreciate that making a clinical diagnosis of sepsis carries 
much greater value than simply identifying ‘poor health’ or general decompensation. Clinical 
outcomes have repeatedly been positively impacted by the rapid administration of broad-spectrum 
antibiotics, IV fluids, and vasopressors if indicated (6, 9). The predictive ability of DeepAISE is 
remarkable because it means at a minimum that preparatory measures to implement sepsis bundles 
can begin much earlier and when appropriate, interventions like antibiotic therapy can be initiated 
sooner. In both instances this has an enormous potential to reduce the expected morbidity and 
mortality for this condition. Sepsis survivors often suffer from high rates of readmission (38) and 
many survivors of sepsis face life-long, debilitating sequelae as a result of the disease (39). Future 
extensions of this work will involve assessing the long-term benefits of competing treatment 
policies using the ATEE framework. Prospective clinical trials will be necessary to confirm this 
supposition; however, our findings provide significant clinical evidence for a radical change to the 
sepsis treatment paradigm that has real-time high-dimensional data analysis and model 
transparency at its center.  
 
Materials and Methods 
Study design 
We performed a retrospective study of all patients admitted to the ICUs at two hospitals within the 
Emory Healthcare system in Atlanta, Georgia from 2014 to 2018. This investigation was 
conducted according to Emory University Institutional Review Board approved protocol #33069. 
External validation of the DeepAISE model was performed on the Medical Information Mart for 
Intensive Care-III (MIMIC-III) ICU database (28), which is a publicly available database 
containing de-identified clinical data of patients admitted to the Beth Israel Deaconess Medical 
Center in Boston, Massachusetts from June 2001 to October 2012. Patients 18 years or older were 
followed throughout their ICU stay until discharge or development of sepsis, according to Sepsis-
3 guidelines (1). The labels of tsuspicion, tSOFA, tsepsis-3, teSOFA, and tsepsis-CDC are used extensively 
throughout the work to define key time points and are clearly described in Table 1. For the purpose 
of defining sepsis, the order-time of antibiotics and cultures were obtained. For the purpose of 
checking treatment durations, the administration time-stamps of antibiotics was considered. 
For the Emory cohort, data from the EHR (Cerner, Kansas City, MO) were extracted through a 
clinical data warehouse (MicroStrategy, Tysons Corner, VA). High-resolution heart rate and Mean 
arterial pressure time series at 2 seconds resolution were collected from select ICUs, through the 
BedMaster system (Excel Medical Electronics, Jupiter, FL), which is a third-party software 
connected to the hospital’s General Electric monitors for the purpose of electronic data extraction 
and storage of high-resolution waveforms. Patients were excluded if they developed sepsis within 
the first 4 hours of ICU admission (by analyzing pre-ICU IV antibiotic administration and culture 
acquisition) or if their length of ICU stay was less than 8 hours or more than 20 days. 
The Emory cohort contained a total of 25,820 patients, 1,445 of whom met the Sepsis-3 criterion 
four hours or later after ICU admission. Out of the 25,820 patients, 70% of them were used for 
developing the model (training set), 10% were used for hyper-parameter optimization, and the 
remaining 20% formed the testing set (see Table S6 for a description of the various holdout datasets 
that have been used for analysis in this paper). The Emory training set contained a total of 18,074 
patients out of which 1,003 patients met the Sepsis-3 criterion, and the Emory testing set contained 
a total of 5,165 patients out of which 287 patients met the Sepsis-3 criterion during their stay in 
the ICU. The MIMIC-III external validation cohort was split in a similar fashion, and more details 
can be found in the Appendix E of Supplementary Material. The DeepAISE model was trained 
and evaluated on both the Emory cohort and the MIMIC-III external validation cohort separately. 
 
Attributable treatment effect estimates (ATEE)  
We first defined a sepsis treatment policy (𝜋"#) associated with a criterion d, d ∈ D = {d1, d2, … 
,dk}, as initiation of antibiotics within t hours of meeting the criterion (e.g., tsepsis-3 or tsepsis-CDC), 
with l ∈ L = {l1, l2, …, lm}, taking either positive or negative values (we take t to belong to an 
interval l). We considered four different antibiotics administration intervals, namely [-24, –6), [-6, 
0), [0, 3), and [3, 24] hours, corresponding to l1, …, l4, respectively (See Fig. S10). For the purpose 
of ATEE analysis, these intervals at the corresponding lags or delays in antibiotics administration 
were considered as treatment levels. 
The propensity score was first introduced as a statistical tool in observational studies to select a 
control cohort for treatment effect estimation for binary treatments and binary outcomes (40). The 
method of Generalized Propensity Score (GPS) was developed to extend effect estimation to the 
case of multi-level (or categorical) treatments. More formally, the GPS is the conditional 
probability that the n-th individual with covariates C(n) receives a treatment level, where C(n) 
corresponds to the n-th patient’s covariates measured prior to administration of antibiotics. 
The propensity to receive a given level of treatment l (e.g. antibiotics within three hours of  tsepsis-
3),  denoted by 𝐺𝑃𝑆(𝑙*𝐶(-)/, was then modeled using a multi-class feedforward neural network 
(namely the GPS-network, see Fig. S11(a)), where given the set of covariates C(n) prior to 
administration of antibiotics, the model returned the patients' propensity to receive a treatment 
level, l. This propensity score enabled us to assess the effects of a given treatment level on the 
patient outcome (Y), through causal inference with discrete treatment levels and binary outcomes 
(41, 42). Creating an averaged dose response function (ADRF) by mapping the received treatment 
levels and the associated GPS to the outcome of interest (e.g., hospital survival) allowed us to 
explore counterfactual reasoning for timing of antibiotics. That is, ‘how might a patient's outcome 
change if the patient was given levels of treatment different from the hospital policy?’. The ADRF 
function was modeled through another feedforward neural network (namely the survival network, 
see Fig. S11(b)), followed by isotonic least squares regression to ensure calibrated estimates of 
outcomes. The input to the ADRF network was a combination of the one-hot encoded vector of 
the treatment level, and the GPS corresponding to the treatment level.  
Given a set of clinical observations and a counterfactual level of treatment, the GPS-network was 
first used to map the observations to GPS scores for the actual and counterfactual treatment levels. 
Next, the GPS scores and the actual and counterfactual treatment levels were separately fed into 
the ADRF model to estimate the expected effect size (Δ(𝜋"#)) associated with a given policy and 
treatment level: 
Δ(𝜋"#) 	= Ε-4𝑌|𝑙, 𝐺𝑃𝑆(𝑙*𝐶(-)/8 − Ε- :𝑌|𝑙;<(-), 𝐺𝑃𝑆=𝑙;<(-)>𝐶(-)?@ (1) 
                            
where the first term inside the parentheses on the right-hand-side of the question was the propensity 
adjusted expected survival associated with the counterfactual treatment level l, and the second term 
was the propensity adjusted expected survival associated with the actual treatment level, 𝑙;<(-) for 
patient n. For each criterion and treatment level, we trained the GPS and ADRF networks 50 times, 
using random initialization of network parameters, to obtain confidence intervals for our 
estimation of Eq. 1. 
 
Development of the DeepAISE model 
DeepAISE began producing scores four hours after ICU admission, and it was designed to predict 
(on an hourly basis) the probability of onset of sepsis within the next 2, 4, 6, 8, 10 and 12 hours. 
The two distinct characteristics of the model were a) utilization of a class of deep learning 
algorithms for multivariate time series data known as the Gated Recurrent Unit (GRU) that allows 
for modeling the clinical trajectory of a patient over time (38), and b) deployment of a parametric 
survival model called the Weibull Cox proportional hazards (WCPH), which casts the problem of 
sepsis prediction to a time-to-event prediction framework and allows for handling of right censored 
outcomes (16), using the features learned from the underlying GRU model. The parametric 
survival model allows for efficient end-to-end learning of the GRU and the WCPH parameters 
using standard deep learning optimization techniques(43). 
In preparation for time series modeling, the longitudinal data of patients were binned into 
consecutive windows of 1-hour duration, with the survival data for each of the time bins 
comprising of three elements: a set of input features x, the time to sepsis event 𝝉 and sepsis event 
indicator e.  If a sepsis event occurred within the prediction horizon, the time interval 𝝉 would 
correspond to the duration of time between the time at which sepsis event occurred and the time 
of collection of features x, with the sepsis event indicator e set to 1. If sepsis did not occur within 
the prediction horizon, the time interval 𝝉 would correspond to one hour more than the duration of 
the prediction horizon, with the sepsis event indicator e set to 0 (i.e., a right-censored event). 
Instead of feeding the features of a patient directly to a WCPH model, we first fed the longitudinal 
data of patients into a GRU model followed by a feedforward neural network (FFNN) to learn a 
representation of patient’s trajectory at the current time-step, which was then fed to the WCPH 
model for time-to-event analysis. The WCPH model, a parametric counterpart to the familiar Cox 
proportional hazards model (44), represents the instantaneous risk of sepsis 𝐻(𝑡) as a product of a 
baseline hazard function, 𝐻D(𝑡) = =EF? =GF?EHI, and the patient-specific sepsis risk which depends 
on the output of the GRU-FFNN module (or representations of a patient’s clinical trajectory at 
time t): 
𝐻(𝑡) = 𝐻D(𝑡)	𝑒𝑥𝑝=𝛽N𝑓(𝑥G)?  (2) 
In the above equation, 𝑓(𝑥G) denotes the output from the GRU-FFNN module, 𝛽 represents the 
patient-specific hazard parameters, 𝜆>0 was a scale parameter and 𝜈>0 was a shape parameter for 
the Weibull distribution. The DeepAISE model (schematic diagram shown in Fig. S2) employed 
a combination of 2-layer stacked GRU-FFNN framework and a modified WCPH model to predict 
the onset of sepsis at a regular interval of 1 hour. The parameters of the DeepAISE model, 
including the WCPH weight vector 𝛽, parameters of the GRU-FFNN were then learnt end-to-end 
by employing a mini-batch stochastic gradient descent approach to minimize the negative-log 
likelihood of the data. More technical details of the DeepAISE model and learning the model 
parameters can be found in Appendix B of Supplementary Materials. To make predictions on new 
patients, we used the trained model parameters and passed the longitudinal patient data 
sequentially through the GRU-FFNN, and the WCPH model to compute the survival scores, which 
provided the probability of not getting sepsis over the prediction horizon. The predicted probability 
of the sepsis event occurring within the prediction horizon was then defined as one minus the 
survival score. 
 
Model evaluation and statistical analysis 
For all continuous variables, we have reported median ([25th - 75th percentile]) and used a two-
sided Wilcoxon rank-sum test when comparing two populations. For binary variables, we have 
reported percentages and use a two-sided chi-square test to assess differences in proportions 
between two populations. The area under receiver operating characteristic (AUC) curves statistics, 
specificity (1-false alarm rate) and accuracy at a fixed 85% sensitivity level were calculated to 
measure the performance of the models. We have reported the DeepAISE performance results for 
four hours ahead prediction for both the training set and testing set on the Emory cohort and the 
MIMIC-III external validation cohort. Additionally, we have also reported the performance results 
for 2, 4, 6, 8, 10 and 12 hours ahead prediction of onset of sepsis. Statistical comparison of all 
AUC curves was performed using the method of DeLong et al. (45). 
 Parameter Optimization 
We trained each model for a total of 200 epochs using the Adam optimizer (43), with a learning 
rate fixed at 1e-2. The mini-batch size was fixed at a total of 1,000 patients (90% control patients, 
10% septic patients), with data randomly sampled (with replacement) in every epoch. To minimize 
overfitting and to improve the generalizability of the model, L1-L2 regularization was used with 
L2 regularization parameter set to 1e-3 and L1 regularization parameter set to 1e-5. Our final 
model had 2 GRU layers stacked on top of each other with the size of hidden state being 100 per 
layer, followed by 1 fully connected layer with the size of the hidden state being 100, and the 
output of which was fed into a modified Weibull-Cox proportional hazards model for prediction 
of onset of sepsis. All of the hyper-parameters of the model: Number of GRU layers, the size of 
hidden state in each of GRU layers, Number of fully connected layers, the size of hidden state in 
each of the fully connected layers, learning rate, mini-batch size, L1 regularization parameter, and 
L2 regularization parameter were optimized using Bayesian optimization (46). All pre-processing 
of the data was performed using Numpy (47), with the rest of the pipeline implemented using 
TensorFlow (48). 
Testing the validity of the relevance scores and model interpretability 
For a given risk score calculation the contribution of the individual input features was calculated 
using the associated relevance scores, by calculating the gradient of the sepsis risk score with 
respect to all input features and element-wise multiplication by the corresponding input features. 
The resultant scores, also known as the relevance scores, were then z-scored and the top 10 features 
(i.e., most frequently observed features across patients and across time) with a z-score of larger 
than 1.96 (corresponding to a 95% confidence interval) were reported for analysis of the overall 
importance of input risk factors (or ‘global interpretability’). To test the hypothesis that the 
individual relevance scores capture meaningful information about the contribution of each input 
feature to the risk scores, we performed a series of studies in which we systematically masked (or 
treated as missing data) 1) the top 10 features with the largest positive and negative relevance 
scores in a global sense (global feature replacement analysis), 2) the top 10 locally important 
features for each individual risk scores (local feature replacement analysis) and 3) a random set 
of 10 features at each point in time (repeated 100 times), and calculated the resulting risk scores 
produced by DeepAISE and the corresponding AUCs. This analysis allowed us to systematically 
compare the contribution of the locally important features against the globally important predictors 
and against the 95-percentile of a randomly selected set of features. 
Real-time implementation details 
To facilitate real-time decision support with DeepAISE, a software platform was developed. The 
platform is responsible for interfacing with an EHR to obtain real-time patient data, computing 
hourly DeepAISE scores, and presenting the results in an interpretable, clinically meaningful 
fashion. The platform consists of four distinct microservices as shown in Fig. 5. These 
microservices are containerized using Docker. The four microservices are: 
a) DeepAISE Model Service: The DeepAISE model is wrapped in a python wrapper and 
exposes a REST API that allows an external entity to run the model, in a stateless inference 
mode, and return a DeepAISE score given a set of observations about a patient. The 
stateless nature refers to the fact that, in a clustered deployment of the model, predictions 
about a patient are not tied to a specific worker node. This makes the system highly scalable 
and it can leverage popular orchestration systems such as Kubernetes and Docker Swarm 
to scale on-demand, in response to fluctuations in system load. Finally, for security needs, 
the system maintains an audit log of every request it receives, and whether the request was 
successfully executed. 
b) Results Database Service: This is the core data management layer of the DeepAISE 
platform and consists of MongoDB and a Java based web service that is responsible for 
providing a REST API as well as the necessary security and auditing infrastructure. The 
data is organized as binary JSON documents, where each document represents the raw 
information (observations, measurements, etc.) and the DeepAISE predictions (scores, 
contributing factors etc.) about a specific patient, at a specific point in time. The 
organization of the data in this fashion allows us to make time series requests and query 
for population trends in the past n hours as well as take deeper dives into an individual 
patient’s data. 
c) Data Orchestrator Service: This is the data system that interfaces with the healthcare IT 
systems. It is responsible for fetching patient data (observations, measurements etc.), and 
transform them into the JSON document structure described above. It posts this data to the 
DeepAISE Model Service and then incorporates the returned results into the JSON 
document before posting them to the Results Database Service. It also maintains systems 
information, tracking uptime, as well as population characteristics that could be used to 
detect anomalies in data 
d) User Interface Service: This is the service that serves the user facing interfaces. It presents 
a dashboard that provides a ranked presentation of patients at risk for sepsis (see Fig.6, 
‘Under Observation’ column). Creating a card for each patient that concisely displayed 
their sepsis risk on the front and provided the top contributing factors on the card’s opposite 
side made it easier for the clinical team to investigate impending cases of sepsis. A second 
drag-and-drop column allowed for clinicians to identify patients that have been reviewed 
and for whom no immediate action was deemed necessary (see Fig.6, ‘Snoozed Alarms’ 
column). Situational awareness was further improved by the movement of septic patients 
to a third column (see Fig.6, ‘Treatment Initiated’ column) indicating that a sepsis related 
treatment had been initiated. 
A web-based version of the DeepAISE software pipeline, with anonymized data, is currently 
available in demo-mode (https://sepsis.app/ ; username:demo, password:demo).  
References and Notes 
1. M. Singer, C. S. Deutschman, C. W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, R. 
Bellomo, G. R. Bernard, J.-D. Chiche, C. M. Coopersmith, R. S. Hotchkiss, M. M. Levy, J. C. 
Marshall, G. S. Martin, S. M. Opal, G. D. Rubenfeld, T. van der Poll, J.-L. Vincent, D. C. Angus, 
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3), JAMA 
315, 801–810 (2016). 
2. C. Rhee, R. Dantes, L. Epstein, D. J. Murphy, C. W. Seymour, T. J. Iwashyna, S. S. Kadri, D. 
C. Angus, R. L. Danner, A. E. Fiore, J. A. Jernigan, G. S. Martin, E. Septimus, D. K. Warren, A. 
Karcz, C. Chan, J. T. Menchaca, R. Wang, S. Gruber, M. Klompas, Incidence and trends of 
sepsis in US hospitals using clinical vs claims data, 2009-2014, JAMA 318, 1241–1249 (2017). 
3. C. M. Torio, B. J. Moore, in Healthcare Cost and Utilization Project (HCUP) Statistical 
Briefs, (Agency for Healthcare Research and Quality (US), Rockville (MD), 2006). 
4. R. P. Dellinger, J. M. Carlet, H. Masur, H. Gerlach, T. Calandra, J. Cohen, J. Gea-Banacloche, 
D. Keh, J. C. Marshall, M. M. Parker, G. Ramsay, J. L. Zimmerman, J.-L. Vincent, M. M. Levy, 
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock, 
Intensive Care Medicine 30, 536–555 (2004). 
5. A. K. Venkatesh, U. Avula, H. Bartimus, J. Reif, M. J. Schmidt, E. S. Powell, Time to 
antibiotics for septic shock: evaluating a proposed performance measure, The American Journal 
of Emergency Medicine 31, 680–683 (2013). 
6. S. A. Sterling, W. R. Miller, J. Pryor, M. A. Puskarich, A. E. Jones, The impact of timing of 
antibiotics on outcomes in severe sepsis and septic shock: A systematic review and meta-
analysis, Critical Care Medicine 43, 1907–1915 (2015). 
7. A. Rhodes, G. Phillips, R. Beale, M. Cecconi, J. D. Chiche, D. De Backer, J. Divatia, B. Du, 
L. Evans, R. Ferrer, M. Girardis, D. Koulenti, F. Machado, S. Q. Simpson, C. C. Tan, X. 
Wittebole, M. Levy, The Surviving Sepsis Campaign bundles and outcome: results from the 
International Multicentre Prevalence Study on Sepsis (the IMPreSS study), Intensive Care 
Medicine 41, 1620–1628 (2015). 
8. R. Ferrer, I. Martin-Loeches, G. Phillips, T. M. Osborn, S. Townsend, R. P. Dellinger, A. 
Artigas, C. Schorr, M. M. Levy, Empiric antibiotic treatment reduces mortality in severe sepsis 
and septic shock from the first hour: results from a guideline-based performance improvement 
program, Critical Care Medicine 42, 1749–1755 (2014). 
9. M. M. Levy, A. Rhodes, The Surviving Sepsis Campaign Bundle: 2018 Update, Critical Care 
Medicine 46, 4 (2018). 
10. C. M. DesRoches, E. G. Campbell, S. R. Rao, K. Donelan, T. G. Ferris, A. Jha, R. Kaushal, 
D. E. Levy, S. Rosenbaum, A. E. Shields, Electronic health records in ambulatory care—a 
national survey of physicians, New England Journal of Medicine 359, 50–60 (2008). 
11. T. Desautels, J. Calvert, J. Hoffman, M. Jay, Y. Kerem, L. Shieh, D. Shimabukuro, U. 
Chettipally, M. D. Feldman, C. Barton, D. J. Wales, R. Das, Prediction of sepsis in the intensive 
care unit with minimal electronic health record data: A machine learning approach, JMIR 
Medical Informatics 4, e28 (2016). 
12. S. Horng, D. A. Sontag, Y. Halpern, Y. Jernite, N. I. Shapiro, L. A. Nathanson, Creating an 
automated trigger for sepsis clinical decision support at emergency department triage using 
machine learning, PloS one 12, e0174708 (2017). 
13. S. M. Brown, J. Jones, K. G. Kuttler, R. K. Keddington, T. L. Allen, P. Haug, Prospective 
evaluation of an automated method to identify patients with severe sepsis or septic shock in the 
emergency department, BMC Emergency Medicine 16, 31 (2016). 
14. K. K. Giuliano, Physiological monitoring for critically ill patients: testing a predictive model 
for the early detection of sepsis, Am. J. Crit. Care 16, 122–130; quiz 131 (2007). 
15. S. P. Shashikumar, Q. Li, G. D. Clifford, S. Nemati, Multiscale network representation of 
physiological time series for early prediction of sepsis, Physiological Measurement 38, 2235–
2248 (2017). 
16. S. Nemati, A. Holder, F. Razmi, M. D. Stanley, G. D. Clifford, T. G. Buchman, An 
interpretable machine learning model for accurate prediction of sepsis in the ICU, Critical Care 
Medicine 46, 547–553 (2018). 
17. K. E. Henry, D. N. Hager, P. J. Pronovost, S. Saria, A targeted real-time early warning score 
(TREWScore) for septic shock, Science Translational Medicine 7, 299ra122-299ra122 (2015). 
18. C. Lin, Y. Zhangy, J. Ivy, M. Capan, R. Arnold, J. M. Huddleston, M. Chi, Early diagnosis 
and prediction of sepsis shock by combining static and dynamic information using 
convolutional-LSTM, 2018 IEEE International Conference on Healthcare Informatics (ICHI) , 
219–228 (2018). 
19. A. B. T. G. Awry, Sepsis early warning scoring systems: The ideal tool remains elusive!, J 
Crit Care (2018). 
20. E. H. Shortliffe, M. J. Sepúlveda, Clinical decision support in the era of artificial intelligence, 
JAMA 320, 2199–2200 (2018). 
21. J. Norrie, The challenge of implementing AI models in the ICU, The Lancet Respiratory 
Medicine 6, 886–888 (2018). 
22. C. L. Ventola, The antibiotic resistance crisis: part 1: causes and threats, Pharmacy and 
Therapeutics 40, 277 (2015). 
23. R. P. Dellinger, M. M. Levy, A. Rhodes, D. Annane, H. Gerlach, S. M. Opal, J. E. 
Sevransky, C. L. Sprung, I. S. Douglas, R. Jaeschke, T. M. Osborn, M. E. Nunnally, S. R. 
Townsend, K. Reinhart, R. M. Kleinpell, D. C. Angus, C. S. Deutschman, F. R. Machado, G. D. 
Rubenfeld, S. A. Webb, R. J. Beale, J.-L. Vincent, R. Moreno, Surviving Sepsis Campaign 
Guidelines Committee including the Pediatric Subgroup, Surviving sepsis campaign:  
international guidelines for management of severe sepsis and septic shock:  2012, Critical Care 
Medicine 41, 580–637 (2013). 
24. R. C. Bone, R. A. Balk, F. B. Cerra, R. P. Dellinger, A. M. Fein, W. A. Knaus, R. M. Schein, 
W. J. Sibbald, Definitions for sepsis and organ failure and guidelines for the use of innovative 
therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of 
Chest Physicians/Society of Critical Care Medicine, Chest 101, 1644–1655 (1992). 
25. Center for Disease Control and Prevention, Hospital toolkit for adult sepsis surveillance, US 
Department of Health and Human Services (2018). 
26. Centers for Medicare and Medicaid Services, Sepsis Bundle Project (SEP) - specifications 
manual for national hospital inpatient quality measures discharges 10-01-15 (4Q15) through 06-
30-16 (2Q16) (2016). 
27. N. Kreif, R. Grieve, I. Díaz, D. Harrison, Evaluation of the effect of a continuous treatment: 
A machine learning approach with an application to treatment for traumatic brain injury, Health 
Economics 24, 1213–1228 (2015). 
28. A. E. Johnson, T. J. Pollard, L. Shen, H. L. Li-wei, M. Feng, M. Ghassemi, B. Moody, P. 
Szolovits, L. A. Celi, R. G. Mark, MIMIC-III, a freely accessible critical care database, Scientific 
Data 3, 160035 (2016). 
29. C. W. Seymour, V. X. Liu, T. J. Iwashyna, F. M. Brunkhorst, T. D. Rea, A. Scherag, G. 
Rubenfeld, J. M. Kahn, M. Shankar-Hari, M. Singer, C. S. Deutschman, G. J. Escobar, D. C. 
Angus, Assessment of clinical criteria for sepsis: for the Third International Consensus 
Definitions for Sepsis and Septic Shock (Sepsis-3), JAMA 315, 762–774 (2016). 
30. C. Rhee, Z. Zhang, S. S. Kadri, D. J. Murphy, G. S. Martin, E. Overton, C. W. Seymour, D. 
C. Angus, R. Dantes, L. Epstein, D. Fram, R. Schaaf, R. Wang, M. Klompas, Sepsis surveillance 
using adult sepsis events simplified eSOFA criteria versus sepsis-3 sequential organ failure 
assessment criteria*:, Critical Care Medicine 47, 307–314 (2019). 
31. K. Cho, B. Van Merriënboer, C. Gulcehre, D. Bahdanau, F. Bougares, H. Schwenk, Y. 
Bengio, Learning phrase representations using RNN encoder-decoder for statistical machine 
translation, arXiv preprint arXiv:1406.1078 (2014). 
32. K. Simonyan, A. Vedaldi, A. Zisserman, Deep inside convolutional networks: Visualising 
image classification models and saliency maps, arXiv preprint arXiv:1312.6034 (2013). 
33. V. Barak, A. Schwartz, I. Kalickman, B. Nisman, G. Gurman, Y. Shoenfeld, Prevalence of 
hypophosphatemia in sepsis and infection: the role of cytokines, The American Journal of 
Medicine 104, 40–47 (1998). 
34. W.-Y. Chen, Y. Song, H. Bai, C.-J. Lin, E. Y. Chang, Parallel spectral clustering in 
distributed systems, IEEE transactions on pattern analysis and machine intelligence 33, 568–
586 (2011). 
35. R. C. Amland, B. B. Sutariya, Quick sequential [sepsis-related] organ failure assessment 
(qSOFA) and St. John sepsis surveillance agent to detect patients at risk of sepsis: an 
observational cohort study, Am J Med Qual 33, 50–57 (2018). 
36. I. Cortés-Puch, C. S. Hartog, Opening the debate on the new sepsis definition change is not 
necessarily progress: revision of the sepsis definition should be based on new scientific insights, 
Am. J. Respir. Crit. Care Med. 194, 16–18 (2016). 
37. A. H. Carneiro, P. Póvoa, J. A. Gomes, Dear Sepsis-3, we are sorry to say that we don’t like 
you, Rev Bras Ter Intensiva 29, 4–8 (2017). 
38. S. K. Gadre, M. Shah, E. Mireles-Cabodevila, B. Patel, A. Duggal, Epidemiology and 
predictors of 30-day readmission in patients with sepsis, Chest 155, 483–490 (2019). 
39. M. Shankar-Hari, G. D. Rubenfeld, Understanding long-term outcomes following sepsis: 
implications and challenges, Current infectious disease reports 18, 37 (2016). 
40. P. R. Rosenbaum, D. B. Rubin, The central role of the propensity score in observational 
studies for causal effects, Biometrika 70, 41–55 (1983). 
41. K. Hirano, G. W. Imbens, The propensity score with continuous treatments, Applied 
Bayesian modeling and causal inference from incomplete-data perspectives 226164, 73–84 
(2004). 
42. K. Imai, D. A. Van Dyk, Causal inference with general treatment regimes: Generalizing the 
propensity score, Journal of the American Statistical Association 99, 854–866 (2004). 
43. D. P. Kingma, J. Ba, Adam: A method for stochastic optimization, arXiv preprint 
arXiv:1412.6980 (2014). 
44. D. R. Cox, in Breakthroughs in statistics, (Springer, 1992), pp. 527–541. 
45. E. R. DeLong, D. M. DeLong, D. L. Clarke-Pearson, Comparing the areas under two or more 
correlated receiver operating characteristic curves: a nonparametric approach, Biometrics , 837–
845 (1988). 
46. J. Snoek, H. Larochelle, R. P. Adams, Practical bayesian optimization of machine learning 
algorithms, Advances in Neural Information Processing Systems , 2951–2959 (2012). 
47. T. E. Oliphant, A guide to NumPy (Trelgol Publishing USA, 2006). 
48. M. Abadi, P. Barham, J. Chen, Z. Chen, A. Davis, J. Dean, M. Devin, S. Ghemawat, G. 
Irving, M. Isard, Tensorflow: a system for large-scale machine learning., OSDI 16, 265–283 
(2016). 
49. J-L. Vincent, R. Moreno, J. Takala, S. Willatts, A. De Mendon, H. Bruining, C.K. Reinhart, 
P.M. Suter, L.G. Thijs, The SOFA (Sepsis-related Organ Failure Assessment) score to describe 
organ dysfunction/failure, Intensive Care Med 5, 707-710 (1996). 
50. M. Costa, A.L. Goldberger, C-K. Peng, Multiscale entropy analysis of complex physiologic 
time series, Physical Review Letters 89, 068102 (2002) 
51. S. Nemati, B.A. Edwards, J. Lee, B. Pittman-Polletta, J.P. Butler, A. Malhotra, Respiration 
and heart rate complexity: effects of age and gender assessed by band-limited transfer entropy, 
Respiratory Physiology & Neurobiology 189, 27 (2013). 
 
Acknowledgments: We would like to acknowledge our funding sources. Additionally, we would 
like to thank Drs. Andre Holder and Russell Jeter for their constructive comments on the 
manuscript, and the members of our tele-ICU team especially Dr. Timothy G. Buchman and Cheryl 
Hiddleson for feedback regarding the user interface, Chad Robichaux for help with data extraction 
and curation from the Emory Clinical Data Warehouse, and Fatemeh Amrollahi for her 
contribution to development of the software pipeline. Funding: Dr. Nemati is funded by the 
National Institutes of Health (NIH), award #K01ES025445. Dr. Josef is funded by the Surgical 
Critical Care Initiative (SC2i), funded by the Department of Defense Defense Health Program 
Joint Program Committee 6 / Combat Casualty Care (USUHS HT9404-13-1-0032 and HU0001-
15-2-0001). The opinions or assertions contained herein are the private ones of the author and are 
not to be construed as official or reflecting the views of the Department of Defense, the Uniformed 
Services University of the Health Sciences, the NIH or any other agency of the US Government. 
Author contributions: S.P.S. and S.N. conceived the overall study, developed the network 
architectures, conducted the experiments, and analyzed the data. C.J. provided clinical expertise, 
reviewed patient data and contributed to interpretation of results and the write-up. S.P.S., S.N. and 
A.S. contributed to the software engineering. S.P.S. and C.J. prepared all the figures. S.P.S. wrote 
the initial draft of the manuscript. S.P.S., C.J., A.S. and S.N. wrote and edited the final manuscript. 
Competing interests: The authors declare that they have no competing interests. Data and 
materials availability: MIMIC-III is a de-identified critical care dataset and is publicly available. 
Access to a de-identified data has been made available as a part of the PhysioNet Challenge 2019. 
Access to the computer code used in this research is available upon request to the corresponding 
author. 
 Fig. 1: Comparison of DeepAISE performance on Emory testing set for prediction horizons of 
2, 4, 6, 8, 10 and 12 hours. Comparison of DeepAISE performance with other baseline models.   
DeepAISE = Deep Artificial Intelligence Sepsis Expert  
LR = Logistic Regression  
FFNN = Feedforward Neural Network 
WCPH = Weibull Cox Proportional Hazard layer 
 
 
 Fig. 2: A clinically interpretable example of DeepAISE. The DeepAISE score is shown for a septic 
patient according to the Third International Consensus Definitions for Sepsis (Sepsis-3). 
Commonly recorded hourly vital signs of the patient, including heart rate (HR), mean arterial 
blood pressure (MAP), respiratory rate (RESP), temperature (TEMP), oxygen saturation (O2Sat) 
are shown. The most significant features contributing to the DeepAISE score are listed 
immediately below the DeepAISE Scores (for clarity of presentation, only selected time points 
are shown). The horizontal dashed line indicates the prediction threshold corresponding to a 
sensitivity of 0.85. Refer to Appendix C of Supplementary Material for more details on the 
abbreviated features. 
(A)       (B) 
 
Fig. 3: Visualization of DeepAISE time series covariates performed by spectral clustering. The 
linear trajectory of the DeepAISE score for 2 septic patients from ICU admission until sepsis 
diagnosis is displayed below a larger manifold that makes use of spectral clustering to visually 
display a patient’s physiologic journey through their illness (each point on the graph represents 
one hour of data from one patient).  The colors for both patients in the plots were chosen based 
on the predicted sepsis risk score (green represents the lowest predicted sepsis risk score, and red 
represents the highest predicted sepsis risk score). A similar figure with septic patients 
highlighted is shown in Fig. S5 of Supplementary Material. (A) Patient #1 (P1) was a 63-year-
old female admitted for a left sided subdural hemorrhage who underwent a craniectomy on 
hospital day zero. This patient remained intubated after surgery and began receiving treatment 
for a culture proven ventilator associated pneumonia the afternoon of hospital day number three. 
DeepAISE identified this patient as being septic nearly 24hrs before clinical treatment was 
implemented (See Fig. S6). (B) Patient #2 (P2) was a 70 year old male who was admitted for 
altered mental status and seizures after vascular coiling of a middle cerebral artery (MCA) 
aneurysm. P2 was intubated on admission and began treatment for a culture proven ventilator 
associated pneumonia on hospital day five however DeepAISE made its sepsis prediction nearly 
36 hours prior to this time, after demonstrating a steadily worsening score since admission (See 
Fig. S7).  
 
  
      
 
Fig. 4: Most common features contributing to an elevated risk score. (A) Every hour 
DeepAISE identifies the top features contributing to an individual septic patient’s risk score. The 
left subfigure demonstrates the frequency of the top ten dynamic features (ordered according to 
the magnitude of the relevance score) across the septic patient population (in the Emory cohort) 
preceding tsepsis-3 and the right subfigure demonstrates the frequency of the top five static features 
that are seen preceding tsepsis-3.  Features with positive gradient with respect to the sepsis risk 
score are identified by ‘(+)’. Features with negative gradient with respect to the sepsis risk score 
are identified by ‘(-)’. (B) Summary of performance of DeepAISE (on the Emory testing set) 
when global feature replacement analysis and local feature replacement analysis were 
performed for features with positive relevance score (left subfigure; see Table S4) and negative 
relavance score (right subfigure; see Table S5). Note that the performance (AUC) of DeepAISE 
when a random set of 10 features at each point in time were masked (repeated 100 times) was 
0.899 [0.886, 0.901].  The sensitivity and specificity values reported for global feature 
replacement analysis and local feature replacement analysis were measured at threshold 
corresponding to 0.85 sensitivity for the original model. 
  
 Fig. 5: Block diagram of the DeepAISE software platform. EHR is queried for the required 
data elements (1). EHR data is then prepared by the Data Orchestrator Service and passed to the 
DeepAISE Model Service for DeepAISE score computation (2). The resulting scores are 
computed and returned to the Data Orchestrator Service using a predefined set of API calls (3). 
The scores are then managed by a time series database in the Results Database Service (4), 
which provides the required data for the UI implemented using client-side Javascript. The figure 
inset shows a live integration of DeepAISE UI in a tele-ICU workflow. 
 
 Fig. 6: Screenshot of the clinician facing DeepAISE UI. In the left column, patients are ranked 
in decreasing severity of illness. An individual patient card shows DeepAISE score on the front, 
and upon a single mouse click the card is turned displaying the top causes contributing to the risk 
score (e.g. Temperature, Heart Rate, Platelets). The middle column displays patients that have 
undergone review by a clinician. The right most column displays patients for whom treatment 
has been initiated. 
 
 
 
 
 
 
 
 
 
Table 1: Description of defined time points utilized in the study. 
Time Point Criteria 
tsuspicion 
Clinical suspicion of infection identified as the earlier timestamp of antibiotics 
and blood cultures within a specified duration. (If antibiotics were given first, the 
cultures must have been obtained within 24 hours. If cultures were obtained first, 
then antibiotic must have been subsequently ordered within 72 hours). 
tSOFA The occurrence of end organ damage as identified by a two-point deterioration in SOFA score within a 6-hour period 
tsepsis-3 
The onset time of sepsis-3 is marked when both tsuspicion and tSOFA have 
happened within close proximity to each other. Specifically, tSOFA must occur 
24 hours before tsuspicion or up to 12 hours after the tsuspicion (tSOFA + 24 hours > 
tsuspicion > tSOFA - 12 hours). The earlier of the tSOFA or tsuspicion was assigned to 
tsepsis. 
teSOFA The occurrence of end organ damage as identified by one point or higher eSOFA score within a 6-hour period 
tsepsis-CDC 
The onset time of sepsis-CDC is marked when both tsuspicion and teSOFA have 
happened within close proximity to each other. Specifically, teSOFA must occur 
24 hours before tsuspicion or up to 12 hours after the tsuspicion (teSOFA + 24 hours > 
tsuspicion > teSOFA - 12 hours). The earlier of the teSOFA or tsuspicion was assigned to 
tsepsis-CDC. 
 
 
Table 2: Summary of percent improvement in survival (median[Interquartile range]) as a 
function of elapsed time from different sepsis onset times to antibiotic start time using 
Attributable treatment effect estimates (ATEE).  
 
[-24,-6) hours [-6,0) hours [0,3) hours [3,24] hours 
tsepsis-3, (%) 8.7 [7.6, 10.2] 8.2 [7.4, 9.9] 3.3 [2.1, 4.0] 2.8 [1.9, 3.5] 
tsepsis-CDC, (%) 9.7 [7.3, 10.7] 0.8 [-0.2, 5.3] -3.0 [-4.1, -1.4] 1.1 [0.1, 2.3] 
 
 
 
Table 3: Summary of DeepAISE performance. 
Performance Metric:  
testing set (training set) 
4 hours 6 hours 12 hours 
Emory cohort 
AUC 0.90 (0.94) 0.89 (0.90) 0.88 (0.89) 
Specificity 0.80 (0.89) 0.78 (0.84) 0.73 (0.78) 
MIMIC-III validation cohort 
AUC 0.87 (0.90) 0.86 (0.87) 0.84 (0.86) 
Specificity 0.74 (0.78) 0.72 (0.75) 0.69 (0.73) 
         *  AUC = Area under the Curve  
            Sensitivity was fixed at 0.85 
 
 
 
 
 
 
 
